A 32-year-old man with a known history of epilepsy is brought to the emergency department by ambulance. His roommate reports that the patient has been experiencing continuous generalized tonic-clonic movements for the past 20 minutes without regaining consciousness. Upon arrival, the patient is actively seizing. The airway is secured, and peripheral intravenous access is immediately established. Arrange the following pharmacologic interventions in the correct sequential order of escalation for the management of status epilepticus, from first-line therapy to refractory management.
- 1Intravenous lorazepam
- 2Intravenous fosphenytoin
- 3Intravenous propofol infusion
Answer
The correct sequence for the pharmacologic management of status epilepticus is to administer intravenous lorazepam first, followed by intravenous fosphenytoin, and finally an intravenous propofol infusion if seizures become refractory.
Status epilepticus is a neurologic emergency requiring a step-wise pharmacologic approach. Once the airway, breathing, and circulation are stabilized, the immediate first-line therapy is a rapid-acting intravenous benzodiazepine, such as lorazepam, to quickly terminate the seizure. If the seizure persists, a second-line non-benzodiazepine antiepileptic drug (e.g., fosphenytoin, levetiracetam, or valproic acid) is administered to gain long-term control. If the patient continues to seize despite these measures, the condition is classified as refractory status epilepticus, necessitating third-line treatment with continuous infusions of general anesthetics, such as propofol, midazolam, or pentobarbital.
Step-by-Step Solution
Key Concept
The protocolized pharmacologic escalation for status epilepticus progresses from benzodiazepines (first-line) to non-benzodiazepine antiepileptic drugs (second-line), and finally to general anesthetics (third-line) for refractory cases.
Estimated Time:1m 0s